Switch Obstacles In Europe Threaten OTC Industry Growth – GSK Exec
This article was originally published in The Tan Sheet
Executive Summary
European perceptions that OTC status increases safety risks hinders switch applications, GSK exec Scarlett-Smith contends. He argues OTC buyers are health conscious, adverse events are not isolated to OTCs and despite the centralized switch process, members retain decentralized OTC policies.